Early-phase preclinical study in a murine xenograft model demonstrating proof-of-concept for a novel radiotherapeutic agent with two dosing schedules; results are encouraging but lack human translation, long-term follow-up, and mechanistic detail needed to guide clinical design.
A sound preclinical study combining in vitro and in vivo work in a mouse TNBC model, demonstrating mechanistic plausibility and efficacy enhancement, but lacking human data, clinical endpoints, or direct comparison to standard anti-angiogenic therapy.
This is an in vitro organoid study without clinical outcomes, animal models, or randomized comparison; it demonstrates mechanistic effects of a nutrient combination on signaling pathways in patient-derived tissue but lacks evidence of efficacy in humans or disease prevention.
A mechanistic review proposing an integrated signaling model in TNBC based on existing evidence, without presenting new experimental data or clinical validation.
Mechanistic ex vivo study in transgenic mouse brain tissue showing reduced metabolic reserve in Alzheimer's-like pathology during anesthesia; lacks clinical translation and in vivo validation.